Six weeks before Viktor Axelsen formally drew a line under his career, his personal physician was already telling Danish national broadcaster TV2 Sport that the two-time Olympic champion's chances of returning to international competition were fading. Dr Morten Zebitz's prognosis, published on 7 March 2026, framed the comeback question with rare candour and effectively softened the ground for the retirement that followed on 15 April.
"It doesn't look super positive," Zebitz told TV2 Sport. The single sentence ricocheted across the badminton world and immediately recast a comeback storyline that had, until then, been hovering in cautious-optimism territory.
Zebitz's longer assessment moved the conversation from speculation to clinical detail. "He is badly affected by the back problem he has had again, and this is on top of the basic back problem he has, which is due to the wear and tear he has incurred over several years," he said. "I talk to him continuously. Without saying anything specific, it doesn't look optimistic right now."
The medical timeline behind that statement is the central context. Axelsen, who lifted his second Olympic gold at Paris 2024, exited the All England in March 2025 with sustained back pain and underwent spinal surgery roughly a month after the tournament. The surgery aimed to address a herniated disc, layered atop multi-year wear that had, in the doctor's framing, become structural rather than acute.
His return to the World Tour came in late August 2025. Across the next four tournaments, the underlying biomechanical issue resurfaced. The Dane has not appeared on a competition court since October. By the time of Zebitz's March interview, Axelsen had withdrawn from the 2026 Malaysia Open and the India Open and was confirmed to be skipping the Asian-leg events of the early 2026 calendar.
The most quoted line from Zebitz's March 7 statement was the broader reflection. "Life must also contain something other than badminton at some point," he said. The line, which followed both the medical updates and an explicit acknowledgement that the prognosis was not positive, in effect provided Axelsen the public framing he would later use himself when finalising his retirement.
The doctor's intervention was unusual in elite Danish sport, where medical comments tend to remain narrowly confined to specific events or rehabilitation milestones. Zebitz's decision to speak publicly indicated that Axelsen and his entourage had concluded the back issue was no longer a manageable injury but a structural limit on top-flight singles play, where the punishing reach-and-jump-recover cycles are now executed at speeds 20% higher than they were when Axelsen first entered the world's top 20.
For Danish badminton, the early-March warnings reset the LA28 cycle in advance. Anders Antonsen, the country's other senior men's singles standout, has carried the Danish men's singles flag through Axelsen's prolonged absence, and federation officials have, since the retirement announcement, confirmed they will programme around Antonsen's calendar rather than waiting on a return that, as Zebitz first warned, looked clinically improbable.
For Axelsen himself, Zebitz's words proved a public bridge between an unsustainable comeback narrative and a more realistic resolution. The combination of medical reality and the doctor's own candid framing — "life must also contain something other than badminton at some point" — set the conditions for the retirement decision that BWF formally announced on 15 April.
In hindsight, Zebitz's March intervention reads as the moment Axelsen's career began to formally close. Six weeks later, the man himself confirmed it.
